Ubs Group Ag Armata Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 6,313 shares of ARMP stock, worth $12,310. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,313

Previous 2,357 167.84%

Holding current value

$12,310

Previous $5,000 120.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.85 - $2.82 $7,318 - $11,155	3,956 Added 167.84%	6,313 $11,000
Q3 2024 Nov 14, 2024	BUY	$2.1 - $3.3 $4,947 - $7,774	2,356 Added 235600.0%	2,357 $5,000
Q2 2024 Aug 13, 2024	SELL	$2.4 - $3.9 $1,838 - $2,987	-766 Reduced 99.87%	1 $0
Q1 2024 May 13, 2024	BUY	$2.81 - $4.18 $2,152 - $3,201	766 Added 76600.0%	767 $3,000
Q4 2023 Feb 09, 2024	SELL	$1.95 - $3.24 $4,383 - $7,283	-2,248 Reduced 99.96%	1 $0
Q3 2023 Nov 09, 2023	BUY	$1.1 - $4.35 $2,472 - $9,778	2,248 Added 224800.0%	2,249 $6,000
Q2 2023 Aug 11, 2023	SELL	$1.14 - $1.7 $4,561 - $6,801	-4,001 Reduced 99.98%	1 $0
Q1 2023 May 12, 2023	SELL	$1.1 - $3.58 $3,207 - $10,439	-2,916 Reduced 42.15%	4,002 $6,000
Q4 2022 Feb 08, 2023	BUY	$0.94 - $4.16 $4,740 - $20,978	5,043 Added 268.96%	6,918 $8,000
Q3 2022 Nov 10, 2022	SELL	$3.12 - $4.92 $3,918 - $6,179	-1,256 Reduced 40.11%	1,875 $8,000
Q2 2022 Aug 10, 2022	BUY	$2.97 - $5.4 $1,158 - $2,106	390 Added 14.23%	3,131 $12,000
Q1 2022 May 16, 2022	BUY	$3.9 - $6.32 $2,749 - $4,455	705 Added 34.63%	2,741 $13,000
Q4 2021 Feb 14, 2022	SELL	$2.96 - $5.86 $2,563 - $5,074	-866 Reduced 29.84%	2,036 $11,000
Q3 2021 Nov 15, 2021	BUY	$3.55 - $4.14 $5,097 - $5,945	1,436 Added 97.95%	2,902 $11,000
Q2 2021 Aug 13, 2021	SELL	$3.89 - $4.87 $17,703 - $22,163	-4,551 Reduced 75.64%	1,466 $6,000
Q1 2021 May 12, 2021	BUY	$3.02 - $6.33 $7,688 - $16,116	2,546 Added 73.35%	6,017 $29,000
Q4 2020 Feb 11, 2021	BUY	$2.65 - $3.94 $9,195 - $13,671	3,470 Added 347000.0%	3,471 $10,000
Q3 2020 Nov 12, 2020	SELL	$2.96 - $4.04 $4,946 - $6,750	-1,671 Reduced 99.94%	1 $0
Q2 2020 Jul 31, 2020	SELL	$2.98 - $4.2 $1,805 - $2,545	-606 Reduced 26.6%	1,672 $7,000
Q1 2020 May 01, 2020	BUY	$2.58 - $4.85 $3,864 - $7,265	1,498 Added 192.05%	2,278 $7,000
Q4 2019 Feb 14, 2020	BUY	$3.16 - $4.54 $657 - $944	208 Added 36.36%	780 $3,000
Q3 2019 Nov 14, 2019	SELL	$3.35 - $4.72 $7,778 - $10,959	-2,322 Reduced 80.23%	572 $2,000
Q2 2019 Aug 14, 2019	BUY	$2.75 - $5.6 $7,958 - $16,206	2,894 New	2,894 $12,000

Others Institutions Holding ARMP

# of Institutions

Shares Held

1.39M

Call Options Held

Put Options Held

10.3K

View Full List

About Armata Pharmaceuticals, Inc.

Ticker ARMP
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,144,700
Market Cap $70.5M
Description
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...

More about ARMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account